BRAFV600E and KIT immunoexpression in early-stage melanoma*
Read
6032
Timeswas read the article
2772
Total PDF
3260
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 16 | 5 | 21 |
| 2025 5 | 135 | 66 | 201 |
| 2025 4 | 120 | 35 | 155 |
| 2025 3 | 129 | 53 | 182 |
| 2025 2 | 115 | 64 | 179 |
| 2025 1 | 93 | 61 | 154 |
| 2024 12 | 96 | 44 | 140 |
| 2024 11 | 111 | 53 | 164 |
| 2024 10 | 117 | 54 | 171 |
| 2024 9 | 148 | 75 | 223 |
| 2024 8 | 127 | 96 | 223 |
| 2024 7 | 140 | 108 | 248 |
| 2024 6 | 103 | 64 | 167 |
| 2024 5 | 113 | 46 | 159 |
| 2024 4 | 91 | 79 | 170 |
| 2024 3 | 86 | 66 | 152 |
| 2024 2 | 87 | 70 | 157 |
| 2024 1 | 50 | 38 | 88 |
| 2023 12 | 60 | 54 | 114 |
| 2023 11 | 85 | 73 | 158 |
| 2023 10 | 53 | 65 | 118 |
| 2023 9 | 66 | 76 | 142 |
| 2023 8 | 47 | 33 | 80 |
| 2023 7 | 47 | 22 | 69 |
| 2023 6 | 48 | 34 | 82 |
| 2023 5 | 38 | 27 | 65 |
| 2023 4 | 36 | 24 | 60 |
| 2023 3 | 41 | 43 | 84 |
| 2023 2 | 38 | 44 | 82 |
| 2023 1 | 31 | 32 | 63 |
| 2022 12 | 44 | 29 | 73 |
| 2022 11 | 39 | 51 | 90 |
| 2022 10 | 39 | 34 | 73 |
| 2022 9 | 43 | 57 | 100 |
| 2022 8 | 32 | 39 | 71 |
| 2022 7 | 23 | 34 | 57 |
| 2022 6 | 25 | 53 | 78 |
| 2022 5 | 25 | 54 | 79 |
| 2022 4 | 23 | 49 | 72 |
| 2022 3 | 28 | 55 | 83 |
| 2022 2 | 18 | 27 | 45 |
| 2022 1 | 30 | 65 | 95 |
| 2021 12 | 31 | 46 | 77 |
| 2021 11 | 34 | 58 | 92 |
| 2021 10 | 31 | 75 | 106 |
| 2021 9 | 26 | 50 | 76 |
| 2021 8 | 30 | 42 | 72 |
| 2021 7 | 32 | 55 | 87 |
| 2021 6 | 25 | 47 | 72 |
| 2021 5 | 50 | 59 | 109 |
| 2021 4 | 91 | 124 | 215 |
| 2021 3 | 30 | 42 | 72 |
| 2021 2 | 19 | 11 | 30 |
| 2021 1 | 17 | 8 | 25 |
| 2020 12 | 8 | 4 | 12 |
Show all
